Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.11 0.002
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA bid1870 gCSI pan-cancer AAC 0.19 0.003
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.003
mRNA Docetaxel gCSI pan-cancer AAC -0.19 0.003
mRNA BRD1812 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.1 0.003
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV